Is functional upregulation of the 5-HT(2B) receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?

General Pharmacology

Volumn 33, Issue 6, 1999, Pages 439-447

  Watts, Stephanie W ^a   Harris, Brian ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Artery; BW723C86; Hypertension; Serotonin

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; DEOXYCORTICOSTERONE ACETATE; KETANSERIN; PHENYLEPHRINE; SEROTONIN; SEROTONIN 2B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; HYPERTENSION; MALE; RATS; RATS, INBRED WF; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, SEROTONIN; SODIUM CHLORIDE; UP-REGULATION;

EID: 0033401945     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(99)00040-3     Document Type: Article

References (32)

1. 2B) contractile receptor in the rat stomach fundus. J Med Chem. 39:1996;2773-2780.
2. 2B receptors. Behav Brain Res. 73:1996;149-152.
3. Biesecker G., Koffler D. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. J Immunol. 140:1988;3406-3410.
4. Bockman C.S., Jeffries W.B., Pettinger W.A., Abel P.W. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension. Am J Physiol. 265:1993;H15-H21.
5. Bruner C.A. Vascular responsiveness in rats resistant to aldosterone-salt hypertension. Hypertension. 20:1992;59-66.
6. 2B receptor antagonist. Serotonin. 3:1996;131-144.
7. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmac. 114:1995;400-404.
8. 2+ modulation in genetic hypertension. Hypertension. 14:1989;45-151.
9. Foguet M., Hoyer D., Pardo L.A., Parekh A., Kluxen F.W., Kalkman O., Stuhmer W., Lubbert H. Cloning and functional expression of the rat stomach fundus serotonin receptor. EMBO J. 11:1992;3481-3487.
10. Glusa E., Roos A. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br J Pharmac. 119:1996;3303-3334.
11. Hurley Myers J., Mecca T.E., Webb R.C. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle. J Cardiovasc Pharmac. 7(suppl. 7):1985;S44-S48.
12. Jeffries W.B., McArdle S., Bockman C., Abel P.W., Pettinger W.A. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension. Hypertension. 17:1991;63-71.
13. Kanagy N.L., Webb R.C. Enhanced vascular reactivity to mastoparan, a G protein activator, in genetically hypertensive rats. Hypertension. 23:1994;946-950.
14. Katovich M.J., Hanley K., Schectman O. Development of DOCA/NaCl hypertension in the Wistar-Furth rat (abstract). Physiologist. 34:1991;252.
15. 2B receptor agonist, BW723C86, on three rat models of anxiety. Br J Pharmac. 117:1996;1443-1448.
16. 2F) from rat stomach fundus. Mol Pharmac. 42:1992;549-557.
17. McGregor D.D., Smirk F.H. Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am J Physiol. 219:1970;687-690.
18. Rowland N.E. NaCl appetite in two strains of rat reported to be resistant to mineralocorticoid-induced hypertension. Physiol Behav. 64:1998;49-56.
19. 2B serotonin receptor. FEBS Lett. 342:1994;85-90.
20. Sciotti V., Gallant S. Resistance to mineralocorticoid-induced hypertensive vascular disease. Hypertension. 10:1987;176-180.
21. Thompson L.P., Bruner C.A., Lamb F.S., King C.M., Webb R.C. Calcium influx and vascular reactivity in systemic hypertension. Am J Cardiol. 59:1987;29A-34A.
22. Ullian M.E., Islam M.M., Robinson C.J., Fitzgibbon W.R., Tobin E.T., Paul R.V. Resistance to mineralocorticoids in Wistar-Furth rats. Am J Phyiol. 272:1997;H1454-H1461.
23. Ullian M.E., Robinson C.J., Spicer E.K., Fitzgibbon W.R., Melnick J.Z., Greene E.L. Resistance to mineralocorticoids in Wistar-Furth rats (abstract). Hypertension. 32:1998;132.
24. Vane J.R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmac. 12:1957;344-349.
25. 2F receptor. Mol Pharmac. 43:1993;419-426.
26. 2B receptor. evidence for species differences J Pharmac Exp Ther. 276:1996;720-727.
27. Watts S.W. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J Hypertens. 16:1998;811-822.
28. 2B receptor antagonist LY272015 is antihypertensive in DOCA-salt hypertensive rats. Am J Physiol. 276:1999;H944-H952.
29. 2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension. 26:1995;1056-1059.
30. 2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertension. J Pharmac Exp Ther. 277:1996;1103-1113.
31. Zhang G.X., Ma C.G., Xiao B.G., van de Meide P.H., Link H. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats. Eur J Immunol. 26:1996;2552-2558.
32. Zoda T., Yeh T.M., Krolick K.A. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats. J Immunol. 146:1991;663-670.